Home Multimedia Podcasts Nonsuppressive Drug Therapy for HIV Nonsuppressive Drug Therapy for HIV February 22, 2011 Mark G. Fromhold, Ph.D., Vice President, Manufacturing & Business Development, Koronis Pharmaceuticals /wp-content/uploads/2018/09/gencast_021811.mp3 Drug therapyHIVLentivirusMedicine, Diagnosis, and TherapeuticsMicrobiologyMicroorganismsRetroviridaeRNA virusTherapeuticsVirus Also of Interest StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies Epstein-Barr Virus Has Vulnerable Sites Exposed 89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field StockWatch: Madrigal Shares Soar as FDA Nears Historic MASH Decision Hijacking of Insect Sperm by Microbes Could Inspire Disease Vector Control Related Media Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Emerging Markets Collaborate to Succeed in Post-Pandemic World Breathing Oxygen Back into the Biological Conversation Global Single-Use Network Support Assurance of Supply Resins Address Downstream Purification Concerns Materials Sourcing: Precautions and Improvements for Cell and Gene Therapies Related Content StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies Epstein-Barr Virus Has Vulnerable Sites Exposed 89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field